WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Testosterone Therapy After Hip Fracture in Elderly Women

Phase 2

Completed

Conditions: Hip Fracture
Testosterone Deficiency
Muscle Weakness

First Posted Date: 2006-01-20

Last Posted Date: 2009-02-04

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT00280267

Locations: 🇺🇸
Washington University School of Medicine, Division of Geriatrics and Nutritional Science, Saint Louis, Missouri, United States

PTK and Letrozole in Post-menopausal Women With Advanced Breast Cancer

Phase 2

Terminated

Conditions: Breast Neoplasms

Interventions: Drug: PTK787/ZK222584
Drug: Letrozole

First Posted Date: 2005-12-07

Last Posted Date: 2013-05-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 4

Registration Number: NCT00263198

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Early Phase 1

Completed

Conditions: Breast Neoplasms

Interventions: Dietary Supplement: Calcium carbonate
Other: Placebo
Drug: Vitamin D

First Posted Date: 2005-12-07

Last Posted Date: 2014-09-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 63

Registration Number: NCT00263185

Locations: 🇺🇸
Washington University, St. Louis, Missouri, United States

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients

Phase 2

Terminated

Conditions: Breast Neoplasms

Interventions: Drug: Plavix
Drug: Aspirin

First Posted Date: 2005-12-07

Last Posted Date: 2017-03-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 48

Registration Number: NCT00263211

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Obesity and Nonalcoholic Fatty Liver Disease

Not Applicable

Completed

Conditions: Non-alcoholic Fatty Liver Disease

Interventions: Drug: placebo
Drug: fenofibrate
Drug: Niacin

First Posted Date: 2005-12-07

Last Posted Date: 2018-07-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 51

Registration Number: NCT00262964

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Zometa
Drug: Epirubicin
Drug: Docetaxel
Drug: Trastuzumab
Radiation: External beam radiation
Procedure: Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection

First Posted Date: 2005-10-19

Last Posted Date: 2013-08-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 120

Registration Number: NCT00242203

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Clofarabine

First Posted Date: 2005-10-18

Last Posted Date: 2013-08-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT00241371

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant

Phase 3

Terminated

Conditions: Cytomegalovirus Infections

Interventions: Drug: Valganciclovir
Drug: Ganciclovir

First Posted Date: 2005-10-18

Last Posted Date: 2013-07-23

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 39

Registration Number: NCT00241345

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

Phase 1

Completed

Conditions: Hodgkin Disease
Leukemia, Myelogenous, Chronic
Lymphocytic Leukemia, Chronic
Multiple Myeloma
Lymphoma, Non-Hodgkin
Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Leukemia, Lymphoblastic, Acute

Interventions: Drug: AMD3100
Procedure: Stem Cell Transplant

First Posted Date: 2005-10-18

Last Posted Date: 2017-06-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 92

Registration Number: NCT00241358

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: PTK787/ZK 222584

First Posted Date: 2005-10-17

Last Posted Date: 2014-09-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT00240162

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy